Use of CXCL6 chemokine in the prevention or repair of cartilage defects
US7485310B2 · kind B2 · utility
15Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2004 |
| Grant date | Feb 3, 2009 |
| Priority date | — |
| Expiry date | Sep 26, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention disclosed the expression of CXCL6 by cells which are able to form stable cartilage. The invention describes the use of these cells and of CXCL6 to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects. The invention further describes the use of chemokines in the modulation of progenitor cell differentiation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.